Reckitt Benckiser shares in demand as group lifts revenue target
Move comes as baby-formula business exceeds expectations
Consumer goods group reaffirms full-year targets
Analysts now see consumer goods group as ‘underperform’
Analysts argue company needs to get its ‘growth mojo working again’
Reckitt Benckiser drops out of Pfizer unit race
GSK now in pole position to buy unitMarch 2018
Reckitt Benckiser CEO stands by Mead Johnson deal
Consumer goods giant has no regrets about acquisitionMarch 2018
Liberum upbeat on Reckitt Benckiser’s potential bid for Pfizer business
Analysts retain ‘buy’ stance but trim rating on FTSE 100 groupMarch 2018
AJ Bell points to Reckitt Benckiser’s tepid growth guidance
Comments come after consumer goods group unveils lacklustre salesFebruary 2018
Reckitt Benckiser share price down after results
Group’s like-for-like sales rise two percent in last quarter of 2017February 2018
- More news
Reckitt share price: UK competition regulator questions K-Y acquisition
UK regulator to further examine acquisition of K-Y by ReckittMay 2015
Reckitt Benckiser share price: Group slams India price controls
Curbs undermine profits and incentive to invest in market, says CEOSeptember 2015
Company confirms Merck acquisition talks
Consumer goods group faces competition from Germany’s BayerApril 2014
Reckitt share price opens higher as company reports bumper Q1 sales
Reckitt share price sees one percent rise on back of favourable resultsApril 2015
Reckitt share price continues to climb on takeover talk
Pfizer said to eye UK consumer goods maker for tax inversion advantageSeptember 2015
- More news
About Reckitt Benckiser Group Plc
Reckitt Benckiser Group Plc (LON:RB) is producing and marketing household, toiletry, health and personal care products worldwide. Its key brands include Scholl (foot care and comfort footwear products), Veet (hair removal products), Nurofen (a pain-relief medication), Strepsils (a sore throat medication), Durex condoms, Mucinex (a cold/flu medication), Gaviscon, Clearasil (acne treatment products), Finish (automatic dishwashing products), Calgon water softener, Dettol (antiseptic liquids), Wick air freshener and Vanish stain remover, among others.
Reckitt Benckiser brands can be found in nearly 200 countries around the world. The company operates in Europe, North America, Latin America, the Middle East, North Africa, Sub-Saharan Africa, Turkey, Russia and CIS, Australia and New Zealand.
Headquartered in Slough, United Kingdom, the group was established in 1999 through the merger of UK-based Reckitt & Colman plc and Netherlands-based Benckiser NV.
Rakesh Kapoor is Chief Executive Officer.
The groupâs latest acquisitions include nutritional supplement and vitamin company Schiff Nutrition in 2012. In 2010, Reckitt Benckiser completed the acquisition of SSL International, adding Durex and Scholl to its powerbrands.
Reckitt Benckiser was fined Â£10.2 million by the Office of Fair Trading in October 2010 after the company admitted to anti-competitive practices in the supply of its Gaviscon heartburn treatment to the NHS.